Singapore markets closed

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.5000-0.0700 (-2.72%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
89,789
185,636
241,148
Other short-term investments
7,907
499
27,091
Total cash
97,696
186,135
268,239
Net receivables
772
20,361
5,171
Inventory
0
0
1,606
Other current assets
538
50
12,210
Total current assets
143,809
225,429
315,362
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
163,618
195,443
178,432
Accumulated depreciation
-55,721
-47,176
-32,914
Net property, plant and equipment
107,897
148,267
145,518
Equity and other investments
8,791
6,524
7,007
Intangible assets
718
1,853
1,585
Other long-term assets
-
3
-1
Total non-current assets
117,406
156,647
154,109
Total assets
261,216
382,076
469,471
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
4,972
2,246
-
Accounts payable
21,456
23,762
24,609
Accrued liabilities
9,421
12,483
12,969
Deferred revenues
59
301
452
Other current liabilities
15,680
1,285
6,077
Total current liabilities
62,995
49,348
52,015
Non-current liabilities
Long-term debt
13,569
18,770
24,219
Other long-term liabilities
6,963
1,885
4,617
Total non-current liabilities
72,280
96,254
108,610
Total liabilities
135,275
145,602
160,625
Stockholders' equity
Common stock
2,955
2,945
2,785
Retained earnings
-439,504
-698,326
-587,035
Accumulated other comprehensive income
-28,605
-18,021
-4,089
Total stockholders' equity
117,968
221,293
283,795
Total liabilities and stockholders' equity
261,216
382,076
469,471